X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1454) 1454
Book Review (334) 334
Publication (47) 47
Book Chapter (7) 7
Magazine Article (3) 3
Book / eBook (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1226) 1226
humans (1086) 1086
surgery (828) 828
female (703) 703
male (699) 699
middle aged (502) 502
adult (424) 424
aged (388) 388
retrospective studies (269) 269
treatment outcome (267) 267
medicine & public health (251) 251
management (248) 248
risk factors (246) 246
mortality (215) 215
abridged index medicus (214) 214
intraabdominal infections (204) 204
abdomen (191) 191
health aspects (184) 184
anti-bacterial agents - therapeutic use (183) 183
animals (180) 180
gastroenterology & hepatology (170) 170
adolescent (161) 161
abdominal compartment syndrome (156) 156
aged, 80 and over (155) 155
intraabdominal hypertension (154) 154
prospective studies (148) 148
sepsis (148) 148
peritonitis (145) 145
analysis (143) 143
infectious diseases (139) 139
risk-factors (134) 134
intraabdominal pressure (130) 130
abdominal surgery (127) 127
care and treatment (127) 127
laparoscopy (122) 122
complications (121) 121
prognosis (120) 120
antibiotics (119) 119
child (117) 117
gastroenterology (104) 104
intraabdominal infection (104) 104
young adult (102) 102
critical care medicine (100) 100
research (100) 100
pharmacology & pharmacy (96) 96
pediatrics (94) 94
time factors (94) 94
diagnosis (93) 93
prevention (92) 92
infections (91) 91
microbiology (91) 91
postoperative complications (91) 91
rats (85) 85
children (84) 84
intraabdominal abscess (81) 81
pressure (80) 80
appendicitis (79) 79
laparotomy (79) 79
postoperative complications - epidemiology (77) 77
complicated intraabdominal infections (76) 76
intraabdominal infections - drug therapy (76) 76
therapy (76) 76
incidence (73) 73
patients (72) 72
child, preschool (71) 71
infection (71) 71
drainage (70) 70
length of stay (70) 70
anti-bacterial agents - administration & dosage (68) 68
severity of illness index (68) 68
postoperative complications - prevention & control (66) 66
hospitals (65) 65
intraabdominal adhesions (65) 65
intraabdominal infections - etiology (65) 65
appendicitis - surgery (64) 64
medical research (64) 64
medicine, general & internal (64) 64
outcomes (63) 63
intraabdominal infections - microbiology (62) 62
postoperative complications - etiology (62) 62
abscess (61) 61
peritonitis - surgery (61) 61
bacterial infections - drug therapy (60) 60
trauma (60) 60
complications and side effects (59) 59
intraabdominal abscesses (59) 59
intraabdominal infections - complications (59) 59
critically-ill patients (58) 58
follow-up studies (57) 57
hypertension (57) 57
medicine, experimental (57) 57
perforated appendicitis (57) 57
hepatology (56) 56
infant (56) 56
internal medicine (56) 56
open abdomen (56) 56
septic shock (56) 56
emergency medicine (55) 55
guidelines (54) 54
tissue adhesions - prevention & control (54) 54
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1380) 1380
German (29) 29
Spanish (18) 18
Chinese (11) 11
French (10) 10
Russian (6) 6
Japanese (3) 3
Italian (2) 2
Polish (2) 2
Turkish (2) 2
Korean (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 10/2016, Volume 60, Issue 10, pp. 6115 - 6120
Hypervirulent Klebsiella pneumoniae (hvKP) is traditionally defined by hypermucoviscosity, but data based on genetic background are limited.... 
STRAINS | AEROBACTIN | VIRULENCE ANALYSIS | TAIWAN | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | SPECTRUM BETA-LACTAMASES | HONG-KONG | EMERGENCE | PYOGENIC LIVER-ABSCESS | Diabetes Mellitus - pathology | Prevalence | Prospective Studies | Klebsiella Infections - pathology | Humans | Middle Aged | Virulence | Male | Klebsiella pneumoniae - classification | Phylogeny | Multilocus Sequence Typing | Cross Infection - pathology | beta-Lactamases - genetics | Pneumonia, Bacterial - pathology | Gene Expression | Pneumonia, Bacterial - complications | Plasmids - metabolism | Cross Infection - microbiology | Diabetes Mellitus - epidemiology | Plasmids - chemistry | Bacteremia - epidemiology | Bacteremia - pathology | Neoplasms - epidemiology | Intraabdominal Infections - complications | Klebsiella pneumoniae - isolation & purification | Diabetes Complications | Cross Infection - complications | Bacteremia - microbiology | Neoplasms - complications | Klebsiella Infections - epidemiology | Klebsiella pneumoniae - genetics | Adult | Female | beta-Lactamases - metabolism | Cross Infection - epidemiology | Pneumonia, Bacterial - microbiology | Intraabdominal Infections - microbiology | Neoplasms - microbiology | Phylogeography | Bacteremia - complications | Bacterial Proteins - genetics | Serogroup | Klebsiella Infections - complications | Pneumonia, Bacterial - epidemiology | China - epidemiology | Klebsiella Infections - microbiology | Intraabdominal Infections - epidemiology | Diabetes Mellitus - microbiology | Intraabdominal Infections - pathology | Klebsiella pneumoniae - pathogenicity | Bacterial Proteins - metabolism | Aged | Neoplasms - pathology | Index Medicus
Journal Article
Journal of Internal Medicine, ISSN 0954-6820, 06/2012, Volume 271, Issue 6, pp. 608 - 618
Schmidt M, Horvath‐Puho E, Thomsen RW, Smeeth L, Sørensen HT (Department of Clinical Epidemiology, Institute of Clinical Medicine, Aarhus University Hospital,... 
infections | deep venous thrombosis | pulmonary embolism | antibacterial agents | venous thromboembolism | Pulmonary embolism | Infections | Deep venous thrombosis | Antibacterial agents | Venous thromboembolism | CONTROLLED-TRIAL | HOSPITALIZED-PATIENTS | RISK-FACTORS | LOW-DOSE HEPARIN | FATAL PULMONARY-EMBOLISM | PREVENTION | DEEP-VEIN THROMBOSIS | MEDICINE, GENERAL & INTERNAL | INFARCTION | COMMUNITY | MEDICAL PATIENTS | Prevalence | Humans | Middle Aged | Male | Pulmonary Embolism - epidemiology | Urinary Tract Infections - complications | Case-Control Studies | Cross Infection - complications | Venous Thromboembolism - drug therapy | Incidence | Outpatients - statistics & numerical data | Anti-Bacterial Agents - therapeutic use | Bacterial Infections - complications | Pulmonary Embolism - microbiology | Skin Diseases, Bacterial - complications | Female | Community-Acquired Infections - complications | Respiratory Tract Infections - complications | Odds Ratio | Venous Thromboembolism - epidemiology | Bacterial Infections - microbiology | Venous Thromboembolism - diagnosis | Acute Disease | Risk Assessment | Bacterial Infections - drug therapy | Risk Factors | Bacteremia - complications | Medical Records | Logistic Models | Inpatients - statistics & numerical data | Cross Infection - drug therapy | Pulmonary Embolism - diagnosis | Algorithms | Bacterial Infections - epidemiology | Venous Thromboembolism - microbiology | Denmark - epidemiology | Pulmonary Embolism - drug therapy | Aged | Intraabdominal Infections - complications | Index Medicus | Original
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 11/2013, Volume 188, Issue 9, pp. 1100 - 1109
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 21, pp. 1996 - 2005
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 09/2016, Volume 63, Issue 6, pp. 754 - 762
Background. The global emergence of carbapenem-resistant Enterobacteriaceae highlights the urgent need to reduce carbapenem dependence. The phase 3 RECAPTURE... 
acute pyelonephritis | ceftazidime-avibactam | complicated urinary tract infection | INFECTIOUS DISEASES | INITIAL ANTIBIOTIC-THERAPY | ANTIMICROBIAL THERAPY | MICROBIOLOGY | IMMUNOLOGY | INTRAABDOMINAL INFECTION | CARBAPENEM-RESISTANT ENTEROBACTERIACEAE | TREATMENT OPTIONS | BACTERICIDAL ACTIVITY | PSEUDOMONAS-AERUGINOSA | LACTAMASE-PRODUCING ENTEROBACTERIACEAE | SPECTRUM BETA-LACTAMASES | KLEBSIELLA-PNEUMONIAE | Doripenem | Azabicyclo Compounds - administration & dosage | Carbapenems - administration & dosage | Humans | Middle Aged | Male | Pyelonephritis - complications | Urinary Tract Infections - complications | Urinary Tract Infections - drug therapy | Carbapenems - adverse effects | Anti-Bacterial Agents - therapeutic use | Carbapenems - therapeutic use | Ceftazidime - administration & dosage | Adult | Azabicyclo Compounds - therapeutic use | Female | Aged | Anti-Bacterial Agents - adverse effects | Ceftazidime - adverse effects | Pyelonephritis - drug therapy | Anti-Bacterial Agents - administration & dosage | Ceftazidime - therapeutic use | Drug Combinations | Azabicyclo Compounds - adverse effects | Care and treatment | Usage | Pyelonephritis | Clinical trials | Urinary tract infections | Influence | Dosage and administration | Ceftazidime | Antibiotics | Drug resistance | Drug therapy | CRE bacteria | Urinary tract diseases | Index Medicus | and Commentaries
Journal Article
Infection control and hospital epidemiology, ISSN 0899-823X, 08/2015, Volume 36, Issue 8, pp. 981 - 985
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2015, Volume 10, Issue 9, pp. e0137262 - e0137262
Rationale Experimental studies suggest that intra-abdominal infection (IAI) induces biological alterations that may affect the risk of lung infection.... 
MORTALITY | BACTERIAL CLEARANCE | PSEUDOMONAS-AERUGINOSA | MULTIDISCIPLINARY SCIENCES | ANIMAL-MODELS | LIPOPOLYSACCHARIDE | ENDOTOXIN-TOLERANCE | LUNG INJURY | STAPHYLOCOCCUS-AUREUS | ORGAN FAILURE | HUMAN MONOCYTES | Pneumonia, Ventilator-Associated - mortality | Prospective Studies | Humans | Middle Aged | Pseudomonas aeruginosa - growth & development | Male | Bacterial Infections - complications | Female | Bacterial Infections - microbiology | Enterobacteriaceae - growth & development | Databases, Factual | Length of Stay | Shock, Septic - pathology | Intensive Care Units | Intraabdominal Infections - microbiology | Risk Factors | Shock, Septic - complications | Shock, Septic - mortality | Respiration, Artificial | Intraabdominal Infections - mortality | Shock, Septic - microbiology | Intraabdominal Infections - pathology | Pneumonia, Ventilator-Associated - microbiology | Bacterial Infections - pathology | Pneumonia, Ventilator-Associated - complications | Survival Analysis | Aged | Pneumonia, Ventilator-Associated - pathology | Staphylococcus aureus - growth & development | Bacterial Infections - mortality | Intraabdominal Infections - complications | Complications and side effects | Sepsis | Ventilator-associated pneumonia | Prognosis | Research | Risk factors | Pneumonia | Intensive care | Laboratories | Lung | Infections | Data bases | Confidence intervals | Databases | Rodents | Surgery | Pseudomonas aeruginosa | Physiology | Nosocomial infections | Teaching hospitals | Ventilators | Bacterial infections | Mortality | Pancreatitis | Health risks | Intra-abdominal infection | Septic shock | Risk analysis | Patients | Abdomen | Ventilation | Index Medicus
Journal Article
Journal Article
Critical Care, ISSN 1364-8535, 07/2018, Volume 22, Issue 1, pp. 175 - 175
Journal Article